Exosome therapy for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests whether a therapy made from tiny particles called exosomes (derived from stem cells) can help control blood sugar and improve health in people with type 2 diabetes. It may offer a new way to manage the condition without traditional drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 2 diabetes, not type 1.
- You must be between 40 and 65 years old.
- You must not have a serious health condition like an autoimmune disease, cancer, or a severe infection.
- You must not be taking blood-thinning medications or immune-suppressing drugs.
- You cannot be pregnant or have chronic kidney disease that requires dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cells from donated umbilical cords can safely help people with type 2 diabetes who also have kidney damage. It aims to see if this therapy can improve kidney function.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
This trial tests whether a type of stem cell treatment (called cfMSC) can help people with long-standing type 2 diabetes who are not getting good blood sugar control from their current treatments. The therapy aims to improve blood sugar levels and may help preserve the body's ability to produce insulin.
This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.
This trial tests a new stem cell treatment (DT2-SCT) for people with type 2 diabetes who need insulin. It aims to see if the treatment is safe and helps control blood sugar better than a placebo.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.